PHARMACEUTICAL ECONSULTING A/S: Financial statements 2020
CVR: 30815378
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 6,946,670 and a net result of DKK 2,345,127 compared with DKK 1,210,618 the year before. That is an increase of 30.7% compared with the year before. Equity in the 2020 report amounted to DKK 4,047,623. The solvency ratio was 23.6%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 6,946,670
- Profit/Loss
- DKK 2,345,127
- Equity
- DKK 4,047,623
- Total Assets
- DKK 17,131,993
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 6.9M | 2.3M | 4M | 4 |
| 2019 | - | 5.3M | 1.2M | 2.7M | 4 |
| 2018 | - | 3.8M | 1.1M | 2.5M | 4 |
| 2017 | - | 4.1M | 1.9M | 6.4M | 3 |
| 2016 | - | 3M | -301K | 4.5M | - |
Official annual report
How creditworthy is PHARMACEUTICAL ECONSULTING A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2019. Gross profit came to DKK 5,316,382, and the net result was DKK 1,210,618.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.